SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-23-007911
Filing Date
2023-11-13
Accepted
2023-11-13 08:00:46
Documents
59
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM10-Q FOR SEPT 2023 sunshine_i10q-093023.htm   iXBRL 10-Q 771917
2 CERTIFICATION sunshine_ex3101.htm EX-31.1 13682
3 CERTIFICATION sunshine_ex3102.htm EX-31.2 13594
4 CERTIFICATION sunshine_ex3201.htm EX-32.1 5818
5 GRAPHIC sunshinelogo.jpg GRAPHIC 6215
  Complete submission text file 0001683168-23-007911.txt   3746642

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE sbfm-20230930.xsd EX-101.SCH 31611
7 XBRL CALCULATION FILE sbfm-20230930_cal.xml EX-101.CAL 47000
8 XBRL DEFINITION FILE sbfm-20230930_def.xml EX-101.DEF 150553
9 XBRL LABEL FILE sbfm-20230930_lab.xml EX-101.LAB 235364
10 XBRL PRESENTATION FILE sbfm-20230930_pre.xml EX-101.PRE 215911
53 EXTRACTED XBRL INSTANCE DOCUMENT sunshine_i10q-093023_htm.xml XML 389694
Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5
Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41282 | Film No.: 231395230
SIC: 2834 Pharmaceutical Preparations